Stay updated on KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Sign up to get notified when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.

Latest updates to the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page
- Check5 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. Overall, a minor release with no broader content changes.SummaryDifference0.0%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.0%
- Check19 days agoChange DetectedThe web page has been updated to include new information about drug safety and publications related to belumosudil and diffuse cutaneous systemic sclerosis, while some previous location and terminology details have been removed.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.3%
Stay in the know with updates to KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.